Anti-atherogenic Antioxidants Regulate the Expression and Function of Proteasome α-Type Subunits in Human Endothelial Cells
Open Access
- 1 November 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (44), 40497-40501
- https://doi.org/10.1074/jbc.m104882200
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- AtherosclerosisCell, 2001
- 4-Hydroxynonenal As a Biological Signal: Molecular Basis and Pathophysiological ImplicationsAntioxidants and Redox Signaling, 1999
- THE PROTEASOMEAnnual Review of Biophysics and Biophysical Chemistry, 1999
- THE UBIQUITIN SYSTEMAnnual Review of Biochemistry, 1998
- Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.JCI Insight, 1998
- Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.JCI Insight, 1997
- UBIQUITIN-DEPENDENT PROTEIN DEGRADATIONAnnual Review of Genetics, 1996
- Probucol as an antioxidant and antiatherogenic drugFree Radical Biology & Medicine, 1993
- Antioxidant activities of probucol against lipid peroxidationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Molecular cloning of cDNA for proteasomes (multicatalytic proteinase complexes) from rat liver: primary structure of the largest component (C2)Biochemistry, 1989